Publications & Works

Publication Network

Published journal articles indexed by SCI, SSCI, and AHCI

Long-term immunological changes after corrective cardiac surgery

Bilgic-Eltan S., Amirov R., Babayeva R., Yorgun Altunbas M., Karakurt T., Can S., et al.
Scandinavian Journal of Immunology , vol.100, no.6, 2024 (SCI-Expanded) identifier identifier

Molecular and In Silico Analysis of the CHEK2 Gene in Individuals with High Risk of Cancer Predisposition from Türkiye.

Ozdemir O., Bychkovsky B. L., Unal B., Onder G., Amanvermez U., Aydin E., et al.
Cancers , vol.16, no.22, 2024 (SCI-Expanded) identifier

Pushing the boundaries of rare disease diagnostics with the help of the first Undiagnosed Hackathon.

Delgado-Vega A. M., Cederroth H., Taylan F., Ekholm K., Ek M., Thonberg H., et al.
Nature genetics , vol.56, no.11, pp.2287-2294, 2024 (SCI-Expanded) identifier

Rapid genome sequencing for critically ill infants: an inaugural pilot study from Turkey.

Guner Yilmaz B., Akgun-Dogan O., Ozdemir O., Yuksel B., Hatirnaz Ng Ö., Bilguvar K., et al.
Frontiers in pediatrics , vol.12, pp.1412880, 2024 (SCI-Expanded) identifier identifier identifier

Genomic disparity impacts variant classification of cancer susceptibility genes in Turkish breast cancer patients.

Agaoglu N. B., Unal B., Hayes C. P., Walker M., Ng Ö., Doganay L., et al.
Cancer medicine , 2024 (SCI-Expanded) identifier

Memantine and SKF82958 but not an enriched environment modulate naloxone-precipitated morphine abstinence syndrome without affecting hippocampal tPA mRNA levels in rats

Aslan A., Hatirnaz-Ng Ö., Tasar O., Ozbek U., Yamanturk-Celik P.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR , vol.234, 2024 (SCI-Expanded) identifier identifier identifier identifier

Managing CDH1 Cancer Risks in a Child: Complex Decision Making in a Family With Hereditary Diffuse Gastric Cancer

Agaoglu N. B., HATIRNAZ NG Ö., Zemheri I. E., Unal B., Gerenli N., Tosun I., et al.
American Journal of Medical Genetics, Part A , 2024 (SCI-Expanded) identifier identifier

A new line method; A direct test in spinal muscular atrophy screening for DBS

Kubar A., Temel S. G., Beken S., Onder G., Hatirnaz Ö., Korkmaz A., et al.
Molecular Genetics and Genomic Medicine , vol.11, no.12, 2023 (SCI-Expanded) identifier identifier

Perception and management of cancer predisposition in pediatric cancer centers: A European-wide questionnaire-based survey.

Lazic J., Haas O. A., Özbek U., Ripperger T., Byrjalsen A., Te Kronnie G., et al.
Pediatric blood & cancer , vol.70, no.5, 2023 (SCI-Expanded) identifier identifier identifier

Impact of TP53 gene variants on prognosis and survival of childhood acute lymphoblastic leukemia.

Firtina S., Erbilgin Y., Hatirnaz Ng Ö., Karaman S., Karakas Z., Celkan T. T., et al.
Scandinavian journal of clinical and laboratory investigation , vol.83, no.3, pp.187-193, 2023 (SCI-Expanded) identifier identifier identifier

Obstacles and expectations of rare disease patients and their families in Turkiye: ISTisNA project survey results

Hatirnaz Ng Ö., Sahin I., Erbilgin Y., Ozdemir O., Yucesan E., Erturk N., et al.
FRONTIERS IN PUBLIC HEALTH , vol.10, 2023 (SCI-Expanded) Creative Commons License Sustainable Development identifier identifier identifier

Concurrent Pathogenic Variants of BRCA1, MUTYH and CHEK2 in a Hereditary Cancer Family

Agaoglu N. B., HATIRNAZ NG Ö., Unal B., AKGÜN DOĞAN Ö., Amanvermez U., Yildiz J., et al.
CANCER GENETICS , vol.268-269, pp.128-136, 2022 (SCI-Expanded) identifier identifier identifier identifier

Tackling TKI resistance in AML: A commentary on "Inhibition of BCL2A1 by STAT5 inactivation overcomes resistance to targeted therapies of FLT3-ITD/D835 mutant AML." by Yamatani et al.

Hatırnaz Ng Ö., Eşkazan A. E.
Translational oncology , vol.19, pp.101394, 2022 (SCI-Expanded) identifier identifier identifier

Determining T and B Cell development by TREC/KREC analysis in primary immunodeficiency patients and healthy controls

Senturk G., Ng Y. Y., Eltan S. B., Baser D., Ogulur I., Altindirek D., et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY , vol.95, 2022 (SCI-Expanded) Sustainable Development identifier identifier identifier

Primary antibody deficiencies in Turkey: molecular and clinical aspects

Firtina S., Ng Y. Y., HATIRNAZ NG Ö., Kiykim A., Ozek E. Y., Kara M., et al.
IMMUNOLOGIC RESEARCH , vol.70, no.1, pp.44-55, 2022 (SCI-Expanded) Sustainable Development identifier identifier identifier

Zinc finger protein 384 (ZNF384) impact on childhood mixed phenotype acute leukemia and B-cell precursor acute lymphoblastic leukemia

Sudutan T., ERBİLGİN Y., HATIRNAZ NG Ö., KARAMAN S., KARAKAŞ Z., Kucukcankurt F., et al.
LEUKEMIA & LYMPHOMA , vol.63, no.12, pp.2931-2939, 2022 (SCI-Expanded) identifier identifier identifier identifier

Mutational landscape of SARS-CoV-2 genome in Turkey and impact of mutations on spike protein structure.

Hatirnaz N., Akyoney S., Sahin I., Soykam H., Bayram A., Ozdemir Ö., et al.
PloS one , vol.16, no.12, 2021 (SCI-Expanded) Creative Commons License Sustainable Development identifier identifier identifier

Prognostic evidence of LEF1 isoforms in childhood acute lymphoblastic leukemia.

ERBİLGİN Y., Ng Ö., Can I., Firtina S., Kucukcankurt F., KARAMAN S., et al.
International journal of laboratory hematology , vol.43, no.5, pp.1093-1103, 2021 (SCI-Expanded) identifier identifier identifier

Gamma-irradiated SARS-CoV-2 vaccine candidate, OZG-38.61.3, confers protection from SARS-CoV-2 challenge in human ACEII-transgenic mice.

Turan R. D., Tastan C., Kancagi D. D., Yurtsever B., Karakus G. S., Ozer S., et al.
Scientific reports , vol.11, no.1, pp.15799, 2021 (SCI-Expanded) Sustainable Development identifier identifier identifier

Preclinical efficacy and safety analysis of gamma-irradiated inactivated SARS-CoV-2 vaccine candidates

Sir Karakus G., Tastan C., Dilek Kancagi D., Yurtsever B., Tumentemur G., Demir S., et al.
SCIENTIFIC REPORTS , vol.11, no.1, 2021 (SCI-Expanded) Creative Commons License Sustainable Development identifier identifier identifier

Mutational landscape of severe combined immunodeficiency patients from Turkey

Çekiç Ş., Ng Y. Y., Ng Ö., Kıykım A., Özen A. O., Özen A. O., et al.
INTERNATIONAL JOURNAL OF IMMUNOGENETICS , vol.47, no.6, pp.529-538, 2020 (SCI-Expanded) identifier identifier identifier

Copy-number variations in adult patients with chronic immune thrombocytopenia.

YÜCESAN E., Ng Ö., Yalniz F. F., Yilmaz H., SALİHOĞLU A., Sudutan T., et al.
Expert review of hematology , vol.13, no.11, pp.1277-1287, 2020 (SCI-Expanded) Sustainable Development identifier identifier identifier

The potential protective roles of zinc, selenium and glutathione on hypoxia-induced TRPM2 channel activation in transfected HEK293 cells

Ergun D. D., Dursun S., PASTACI ÖZSOBACI N., HATIRNAZ NG Ö., NAZIROĞLU M., ÖZÇELİK D.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION , vol.40, no.6, pp.521-530, 2020 (SCI-Expanded) identifier identifier identifier

Hydrogen Sulphide and Nitric Oxide Cooperate in Cardioprotection Against Ischemia/Reperfusion Injury in Isolated Rat Heart.

ÜSTÜNOVA S., TAKIR S., YILMAZER N., Bulut H., ALTINDİREK D., HATIRNAZ NG Ö., et al.
In vivo (Athens, Greece) , vol.34, no.5, pp.2507-2516, 2020 (SCI-Expanded) Creative Commons License identifier identifier identifier

Lymphoma Predisposing Gene in an Extended Family: CD70 Signaling Defect

Khodzhaev K., Bay S. B., Kebudi R., ALTINDİREK D., Kaya A., Erbilgin Y., et al.
JOURNAL OF CLINICAL IMMUNOLOGY , vol.40, no.6, pp.883-892, 2020 (SCI-Expanded) Sustainable Development identifier identifier identifier

PTEN and AKT1 Variations in Childhood T-Cell Acute Lymphoblastic Leukemia

Kucukcankurt F., Erbilgin Y., Firtina S., Hatirnaz Ö., Karakas Z., Celkan T., et al.
TURKISH JOURNAL OF HEMATOLOGY , vol.37, no.2, pp.98-103, 2020 (SCI-Expanded) Creative Commons License identifier identifier identifier

Prognostic gene alterations and clonal changes in childhood B-ALL.

ERBİLGİN Y., Firtina S., Mercan S., Ng Ö., KARAMAN S., Tasar O., et al.
Leukemia research , vol.83, pp.106159, 2019 (SCI-Expanded) identifier identifier identifier

Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors.

ERBİLGİN Y., Eskazan A. E., HATIRNAZ NG Ö., SALİHOĞLU A., ELVERDİ T., Firtina S., et al.
Leukemia & lymphoma , vol.60, no.1, pp.200-207, 2019 (SCI-Expanded) identifier identifier identifier

A novel pathogenic frameshift variant of CD3E gene in two T-B+ NK+ SCID patients from Turkey.

Firtina S., Ng Y. Y., Ng Ö., Nepesov S., Yesilbas O., Kilercik M., et al.
Immunogenetics , vol.69, no.10, pp.653-659, 2017 (SCI-Expanded) identifier identifier identifier

Dysregulation of the DKK1 gene in pediatric B-cell acute lymphoblastic leukemia

Firtina S., Hatirnaz Ng Ö., Erbilgin Y., Ozbek U., Sayitoglu M.
TURKISH JOURNAL OF MEDICAL SCIENCES , vol.47, no.1, pp.357-363, 2017 (SCI-Expanded) identifier identifier identifier

A Possible Role for WNT5A Hypermethylation in Pediatric Acute Lymphoblastic Leukemia

HATIRNAZ NG Ö., Firtina S., Can I., KARAKAŞ Z., Agaoglu L., DOĞRU Ö., et al.
TURKISH JOURNAL OF HEMATOLOGY , vol.32, no.2, pp.127-135, 2015 (SCI-Expanded) identifier identifier identifier identifier

Deregulated WNT signaling in childhood T-cell acute lymphoblastic leukemia

HATIRNAZ NG Ö., ERBİLGİN Y., Firtina S., Celkan T., KARAKAŞ Z., Aydogan G., et al.
BLOOD CANCER JOURNAL , vol.4, 2014 (SCI-Expanded) identifier identifier identifier

LOCAL RENIN-ANGIOTENSIN SYSTEM IN NORMAL HEMATOPOIETIC AND MULTIPLE MYELOMA-RELATED PROGENITOR CELLS

Haznedaroglu I., Uz B., Ozcebe O., Buyukasik Y., Goker H., Aksu S., et al.
HAEMATOLOGICA , vol.98, pp.768, 2013 (SCI-Expanded) identifier

Identification of Interconnected Markers for T-Cell Acute Lymphoblastic Leukemia

Maiorov E. G., Keskin O., Ng Ö., Ozbek U., Gursoy A.
BIOMED RESEARCH INTERNATIONAL , 2013 (SCI-Expanded) identifier identifier identifier

Upregulation of T-Cell-Specific Transcription Factor Expression in Pediatric T-Cell Acute Lymphoblastic Leukemia (T-ALL)

SAYİTOĞLU M., ERBİLGİN Y., HATIRNAZ NG Ö., Yildiz I., Celkan T., Anak S., et al.
TURKISH JOURNAL OF HEMATOLOGY , vol.29, no.4, pp.325-333, 2012 (SCI-Expanded) identifier identifier identifier

Genetic alterations in members of the Wnt pathway in acute leukemia

Erbilgin Y., Ng Ö., Mavi N., Ozbek U., Sayitoglu M.
Leukemia and Lymphoma , vol.53, no.3, pp.508-510, 2012 (SCI-Expanded) identifier identifier identifier

Definition of C282Y mutation in a hereditary hemochromatosis family from Turkey

Yoenal O., Hatirnaz Ö., Akyuez F., Koroglu G., Ozbeik U., Cefle K., et al.
Turkish Journal of Gastroenterology , vol.18, no.1, pp.53-57, 2007 (SCI-Expanded) identifier identifier identifier

HFE gene mutation, chronic liver disease, and iron overload in Turkey

Yoenal O., Hatirnaz Ö., Akyuez F., Oezbek U., Demir K., Kaymakoglu S., et al.
Digestive Diseases and Sciences , vol.52, no.11, pp.3298-3302, 2007 (SCI-Expanded) identifier identifier identifier

The SOCS-1 gene methylation in chronic myeloid leukemia patients

Hatirnaz M., Ure U., Ar C., Akyerli C., Soysal T., Ferhanoglu B., et al.
American Journal of Hematology , vol.82, no.8, pp.729-730, 2007 (SCI-Expanded) identifier identifier identifier

Articles Published in Other Journals

Kronik Myeloid Lösemide BCR-ABL Füzyon Transkriptinin Eş Zamanlı PCR ile Kantitasyonu İçin Referans Plazmid Oluşturulması

NG Y. Y., Yılmaz Z. H., HATIRNAZ NG Ö., SAYİTOĞLU M.
Deneysel Tıp Araştırma Enstitüsü Dergisi , vol.7, no.13, pp.93-100, 2017 (Peer-Reviewed Journal)

Hematolojik Maligniteler Moleküler Genetik Etiyoloji ve 2016 Dünya Sağlık Örgütü Sınıflaması

HATIRNAZ NG Ö., ÖZBEK U.
Türkiye Klinikleri Dergisi Tıbbi Genetik Özel Sayısı , vol.2, no.2, pp.88-98, 2017 (Peer-Reviewed Journal)

First Steps of the Genetic Monitorization in Primary Immune Deficiencies in the Lead of Prof. Dr. Işil Barlan in Turkey

Ng Y. Y., Şişko S., Hatırnaz Ng Ö., Çatal Tatonyan S., Sever Kaya D., Fırtına S., et al.
Turkish Journal of Immunology , vol.3, no.2, pp.47, 2015 (Scopus)

First Steps of the Genetic Monitorization in Primary Immune Deficiencies in the Lead of Prof. Dr. Isil Barlan in Turkey

Ng Y. Y., Sisko S., HATIRNAZ NG Ö., Tatonyan S. C., ŞATANA D., FIRTINA S., et al.
TURKISH JOURNAL OF IMMUNOLOGY , no.2, pp.47, 2015 (ESCI) identifier

8q24 bölgesi çocukluk çağı lenfoblastik lösemiler için potansiyel risk oluşturur mu

HATIRNAZ NG Ö., Can İ., SİNEM F., ERBİLGİN Y., ÖZBEK U., SAYİTOĞLU M.
Deneysel Tıp Dergisi , vol.5, no.9, 2015 (Peer-Reviewed Journal)

AKUT LÖSEMİ HÜCRE SERİLERİNDE BETA KATENİN siRNA UYGULAMALARI

HATIRNAZ NG Ö., ERBİLGİN Y., AKTAŞ E., DENİZ G., ÖZBEK U., SAYİTOĞLU M.
DENEYSEL TIP DERGİSİ , vol.2, no.3, pp.16-22, 2012 (Peer-Reviewed Journal)

BETA KATENİN VE AXIN2 PROTEİNLERİ ETKİLEŞİMLERİNİN PROKSİMİTİ LİGASYON ASSAY YAKINSAL BAĞLANMA TESPİTİ ILE GÖRÜNTÜLENMESİ

ERBİLGİN Y., HATIRNAZ NG Ö., SAYİTOĞLU M., SÖDERBERG O., ÖZBEK U.
DENEYSEL TIP DERGİSİ , vol.1, no.2, pp.24-27, 2011 (Peer-Reviewed Journal)

Sayımsal Gerçek Zamanlı Polimer Zincir Reaksiyonu ve Hematolojik Gen Anlatım Analizleri

SAVLI H., HATIRNAZ Ö.
TÜRKİYE KLİNİKLERİ TIP BİLİMLERİ DERGİSİ , vol.24, no.6, pp.653-660, 2004 (Peer-Reviewed Journal)

Refereed Congress / Symposium Publications in Proceedings

Primer İmmün Yetmezliklerde Rutin Tanı Deneyimi: 2010-2016 Yılları Aziz Sancar Deneysel Tıp Araştırma Enstitüsü, Genetik Anabilim Dalı Verileri

HATIRNAZ NG Ö., NG Y. Y., Şişko S., Çatal Tatonyan S., Firtina S., Sever Kaya D., et al.
3.Klinik İmmünoloji Kongresi, Turkey, 12 April 2017 - 15 April 3017

Statistical Analysis of Genomic in-silico Pathogenicity Predictors

Aydin E., Ergun B., HATIRNAZ NG Ö., ÖZDEMİR Ö.
56th Annual Conference of the European-Society-of-Human-Genetics (ESHG), Glasgow, England, 10 - 13 June 2023, pp.652 identifier

From patient to function: modeling CRIM1 in xenopus tropicalis

AKGÜN DOĞAN Ö., Viviano S., HATIRNAZ NG Ö., Agaoglu N. B., Ji W., Jeffries L., et al.
55th European-Society-of-Human-Genetics (ESHG) Conference, Vienna, Austria, 11 - 14 June 2022, pp.656-657 identifier

Molecular Diagnosis of TYR Negative Albinism Patients by Clinical Exome Sequencing

Akyoney S., Sahin I., Unal B., Agaoglu N. B., Mudun A., Parlakgunes Z., et al.
54th Conference of the European-Society-of-Human-Genetics (ESHG), ELECTR NETWORK, 28 - 31 August 2021, pp.118 identifier

KALITSAL KANSERLERDE KLİNİK ÖNEMİ BİLİNMEYEN GENOMİK VARYANTLARIN FONKSİYONEL KARAKTERİZASYONU VE SINIFLANDIRILMASI

Üstün Yılmaz S., Özdemir Ö., AĞAOĞLU N. B., HATIRNAZ NG Ö., MÜFTÜOĞLU M., ÖZBEK U.
8.TÜRK TIBBİ ONKOLOJİ KONGRESİ, Antalya, Turkey, 3 - 07 November 2021 Sustainable Development

TREC/KREC Kopya Sayılarının Otoimmün Hastalıklarda Araştırılması: İTP ve Hashimoto Tiroiditi Örnekleri

Şahin Kimyon Ö., Altındirek D., Durcan E., Elverdi T., Hatırnaz Ng Ö., Gönen M. S., et al.
47. Ulusal Hematoloji Kongresi, Antalya, Turkey, 4 - 07 November 2021

PRİMER İMMÜN YETMEZLİK HASTALARI VE SAĞLIKLI BİREYLERDE TREC/KREC KOPYA SAYILARININ ANALİZİ VE KULLANIMI: PİLOT ÇALIŞMA

Şentürk G., Ng Y. Y., Sayitoğlu M., Hatırnaz Ng Ö.
45. Ulusal Hematoloji Kongresi, Antalya, Turkey, 30 October - 02 November 2019, pp.138-139

AKUT LÖSEMİ HASTALARINDA “ZINC FINGER PROTEIN 384” (ZNF384) GENİ FÜZYONLARININ TESPİTİ

Sudutan T., Erbilgin Y., Hatırnaz Ng Ö., Karaman S., Sarper N., Sayitoğlu M.
45. Ulusal Hematoloji Kongresi, Antalya, Turkey, 30 October - 02 November 2019, pp.111

Akut Lösemili Hastalarda ’xx’xx Zinc Finger Protein 384’xx’xx (ZNF384) Geni Füzyonlarının Tespiti

Sudutan T., ERBİLGİN Y., HATIRNAZ NG Ö., KARAMAN S., SARPER N., CELKAN T. T., et al.
45. Ulusal Hematoloji Kongresi, Turkey, 30 October - 02 November 2019

CD70 mutations in a family with affected CID indivuduals

Khodzhaev K., HATIRNAZ NG Ö., ERBİLGİN Y., SAYİTOĞLU M.
Highlights of Bertinoro, Predisposition to hereditary Leukemia and Lymphoma Training School, 11 - 12 October 2019

Screening TYR gene variations in Turkish oculocutaneuse albinism patients

Hatırnaz Ng Ö., Özbek U., Alanay Y., Yararbaş K.
Avrupa Insan Genetiği Derneği Kongresi, Gothenburg, Sweden, 15 - 19 June 2019, vol.27, pp.1233-1234

Determination of Zinc Finger Protein 384 (ZNF384) Gene Fusion in Childhood Acute Lymphoblastic Leukemia Patients

Sudutan T., ERBİLGİN Y., HATIRNAZ NG Ö., KARAKAŞ Z., SARPER N., CELKAN T. T., et al.
13th Balkan Congress of Human Genetics, 17 - 20 April 2019

Comprehensive analysis of transcriptomic portrait of T-cell acute lymphoblastic leukemia by RNA sequencing

GÜNGÖRÜRLER E., HATIRNAZ NG Ö., ERBİLGİN Y., Fırtına S., SAYİTOĞLU M.
LEUKEMIA RESEARCH, İstanbul, Turkey, 17 - 20 October 2018, vol.73, pp.64

IKZF1 Deletions at Diagnose and Relapse of Childhood B-ALL

ERBİLGİN Y., Fırtına S., HATIRNAZ NG Ö., CELKAN T. T., KARAKAŞ Z., ANAK S. S., et al.
59th American Society of Heamatology Annual Meeting, 9 December - 12 January 2017

Molecular Diagnosis of SCID patients by a Custom Designed NGS Panel

Fırtına S., SAYİTOĞLU M., HATIRNAZ NG Ö., Kıykım A., Karakoç Aydıner E., Barış S., et al.
IPIC 2017, Dubai, United Arab Emirates, 15 - 17 November 2017

TREC/KREC Analysis and Their Clinical Correlation in Severe Combined İmmune Deficiency

HATIRNAZ NG Ö.
IPIC 2017, Dubai, United Arab Emirates, 8 - 10 November 2017

Çocukluk Çağı T Hücreli Akut Lenfoblastik Lösemi Hastalarında Artmış TUBB2A Anlatımı Tedavi Yanıtını Belirler

Khodzhaev K., Hatırnaz Ng Ö., Tuğcu D., Erbilgin Y., Celkan T. T., Karakaş Z., et al.
43. Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 04 November 2017, pp.9

Çocukluk Çağı B-ALL Hastalarinda IKZF1 Delesyonlarinin Araştırılması

ERBİLGİN Y., HATIRNAZ NG Ö., SAYİTOĞLU M., ÖZBEK U.
43. Ulusal Hematoloji Kongresi, Turkey, 1 - 04 November 2017

SKF82958’xxİN SIÇANLARDA NALOKSON İLE BAŞLATILAN MORFİN YOKSUNLUK SENDROMU BELİRTİLERİ VE HİPOKAMPAL DOKU PLAZMİNOJEN AKTİVATÖRÜ mRNA DÜZEYLERİ ÜZERİNE ETKİLERİ

Aslan A., HATIRNAZ NG Ö., Taşar O., ÖZBEK U., YAMANTÜRK ÇELİK A. P.
24. Ulusal Farmakolji kongresi, Turkey, 17 - 22 October 2017

Effects of enrıched envıronment and memantıne on naloxone precıpıtated morphıne-abstınence syndrome ın rats.

Aslan A., HATIRNAZ NG Ö., ÖZBEK U., YAMANTÜRK ÇELİK A. P.
6th INTERNATIONAL DRUG ABUSE RESEARCH SOCIETY, 4 - 08 September 2017

Effects of enriched environment and memantine on naloxone precipitated morphine-abstinence syndrome in rats

ASLAN A., HATIRNAZ NG Ö., TAŞAR O., ÖZBEK U., YAMANTÜRK ÇELİK A. P.
6th Meeting of the International Drug Abuse Research Society, Dubrovnik, Croatia, 4 - 08 September 2017

Research Biobank for Leukemia

ERBİLGİN Y., HATIRNAZ NG Ö., Fırtına S., Khodzaev K., ÖZBEK U., SAYİTOĞLU M., et al.
Towards Harmonyin Biobanking, Switzerland, 01 June 2017 - 03 June 2107

PTEN AND AKT1 GENE VARIATIONS IN CHILDHOODT-ALL PATIENTS

Küçükcankurt F., HATIRNAZ NG Ö., ERBİLGİN Y., ÖZBEK U., KARAKAŞ Z., CELKAN T. T., et al.
6th International Congress onLeukemia – Lymphoma – Myeloma, 11 - 13 May 2017

Does TUBB2A expression have a prognostic effect in childhood T-ALL patients

Khodzhaev K., HATIRNAZ NG Ö., ERBİLGİN Y., TUĞCU D., SAYİTOĞLU M.
6th International Congress on Leukemia Lymphoma Myeloma, 11 - 16 May 2017

Primer İmmün Yetersizliklerde Hastalıkla İlişkili Aday Varyantların Tespiti

Fırtına S., NG Y. Y., HATIRNAZ NG Ö., CAMCIOĞLU Y., AYDINER E., Kaya A., et al.
12.Ulusal Tıbbi Genetik kongresi, Turkey, 5 - 09 October 2016

Identification of Genetic Variation by Targeted Next Generation Sequencing in Turkish Patients

Fırtına S., SAYİTOĞLU M., HATIRNAZ NG Ö., Kıykım A., AYDINER E., Nepesov S., et al.
ESID 2016, 21 - 24 September 2016

Gene expression patterns in relapsed B cell acute lymphoblastic leukemia and potential therapeutic targets

ERBİLGİN Y., İşek B., Fırtına S., HATIRNAZ NG Ö., İnal A., Doğan P., et al.
ESGH 2016, 27 - 30 May 2016

Detection of genetic variations in severe combined immunodeficiency SCID patients by targeted amplicon sequencing

NG Y. Y., Fırtına S., HATIRNAZ NG Ö., Kıykım A., AYDINER E., Nepesov S., et al.
MIMIC-III, 27 - 30 April 2016

Prognostic Significance of IKZF1 Deletions in Childhood B ALL

ERBİLGİN Y., Fırtına S., HATIRNAZ NG Ö., KARAKAŞ Z., CELKAN T. T., SARPER N., et al.
27th Annual Meeting of the International BFM Study Group, 23 - 26 April 2016

AGIR KOMBINE IMMUN YETMEZLIK HASTALARINDA YENI NESIL DIZILEME YONTEMI ILE GENETIK VARYASUONLARIN SAPTANMASI

Fırtına S., NG Y. Y., HATIRNAZ NG Ö., Kıykım A., AYDINER E., Nepesov S., et al.
2. Klinik İmmünoloji kongresi, Turkey, 31 March - 03 April 2016

KLL de İbrutinib öncesi ve sonrası mutasyonlar İstanbul Lenfoma Gurubu Toplantısı

HATIRNAZ NG Ö.
İstanbul Lenfoma Gurubu Toplantısı, Turkey, 23 January 2016

New CNV Regions Identified in ITP Provide Evidence for Genetic Predisposition

AR M. C., YÜCESAN E., Yalniz F., HATIRNAZ NG Ö., SALİHOĞLU A., Berk S., et al.
57th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 5 - 08 December 2015 identifier

Sensitivity Reproducibility and Clinical Utility Of Next Generation Sequencing NGS for BCR ABL1 Kinase Domain Mutation Screening Results From The CML Work Package Of The Iron II Interlaboratory RObustness Of Next Generation Sequencing International Study

SOVERINI S., ERNST T., KOHLMANN A., DE BENEDITTIS C., ALIKIAN M., FORONI L., et al.
55.th ASH Meeting 2013, 7 - 10 December 2013, vol.122

Pediatrik T ALL hastalarında regulatör mikroRNA ların yolak analizleri ile belirlenmesi

Khodzhaev K., HATIRNAZ NG Ö., ERBİLGİN Y., ÖZBEK U., SAYİTOĞLU M.
14. Tıbbi Biyoloji ve Genetik Kongresi, Turkey, 27 - 30 October 2015

İmmun Trombositopenide Genetik Yatkınlığa Neden Olan Kopya Sayısı Değişiklik CNV Bilgelerinin Belirlenmesi

SAYİTOĞLU M., EMRAH Y., YALNIZ F. F., HATIRNAZ NG Ö., AYŞE S., IŞIL E. Ö., et al.
41. ULUSAL HEMATOLOJİ KONGRESİ, Turkey, 21 - 24 October 2015

KML monitorizasyonunda yeni bir kantitatif analiz raporlama ve takip yazılımı REPTILE

HATIRNAZ NG Ö., ÖZDEMİR Ö., SAYİTOĞLU M., ÖZBEK U.
41. ULUSAL HEMATOLOJİ KONGRESİ, Turkey, 21 - 24 October 2015

T Hücreli Akut Lenfoblastik Lösemi Hücre Hatlarında SKIL geni ve hsa miR 223 Fonksiyonel İlişkisi

HATIRNAZ NG Ö., ORÇUN T., NG Y. Y., CEREN Ö., ÖZBEK U., SAYİTOĞLU M.
41. ULUSAL HEMATOLOJİ KONGRESİ, Turkey, 21 - 24 October 2015

Detection of CD19 ICOS TACI gene mutations in Turkish CVID patients

Sİnem Ş., Ayça K., Safa B., AYDINER E., Serdar N., HATIRNAZ NG Ö., et al.
4th European Congress of Immunology, 6 - 09 September 2015

Down regulation of SnoN SKIL gene in T cell acute lymphoblastic leukemia

HATIRNAZ NG Ö., Taşar O., NG Y. Y., CEREN Ö., ERBİLGİN Y., SAYİTOĞLU M., et al.
5th International Congress of Leukemia Lymphoma Myeloma, 21 - 23 May 2015

Primer immün yetersizliklerde genetik alt yapının yeni dizileme yöntemi ile belirlenmesi

SİNEM F., HATIRNAZ NG Ö., SİNEM Ş., NG Y. Y., ÇINAR S., DENİZ G.
DETAE GENÇ ARAŞTIRICILAR TOPLANTISI 2015, Turkey, 19 - 20 January 2015

Pediatrik ALL Hastalarında LEF1 Mutasyon Analizi

TOZAN F., ERBİLGİN Y., CAN İ., HATIRNAZ NG Ö., TAŞAR O., ŞİŞKO S., et al.
40. ULUSAL HEMATOLOJI KONGRESI, Turkey, 22 - 25 November 2014

İÜ DETAE MOLEKÜLER HEMATOLOJİ ÇALIŞMA GRUBU 1996 2014 YILLARI LÖSEMİLERİN MOLEKÜLER MONİTORİZASYONU

SAYİTOĞLU M., HATIRNAZ NG Ö., ERBİLGİN Y., ALTINDİREK D., SERBEST E., SIRMA EKMEKCİ S., et al.
6. DETAE GÜNLERİ, Turkey, 24 - 25 November 2014

B ALL hastalarında CRLF2 PAX5 JAK2 ve IL7R Gen Mutasyonlarının Amplikon derin dizileme ile tespiti

MERCAN S., TAŞAR O., ŞİŞKO S., ERBİLGİN Y., HATIRNAZ NG Ö., TOZAN F., et al.
40. ULUSAL HAMATOLOJİ KONGRESİ, Turkey, 22 - 25 November 2014

Tirozin Kinaz İnhibitörlerine Dirençli KML Hastalarında Yeni Nesil Dizileme Tekniği ile BCR ABL1 kinaz bölgesi mutasyonlarının Tespiti

ERBİLGİN Y., EŞKAZAN E., HATIRNAZ NG Ö., SALİHOĞLU A., ELVERDİ T., FIRTINA S., et al.
39. ULUSAL HEMATOLOJİ KONGRESİ, Turkey, 23 - 26 November 2013

Genetic and Epigenetic Profile Of Early Relapsed Childhood ALL

ERBİLGİN Y., HATIRNAZ NG Ö., Fıttına S., CELKAN T. T., ANAK S. S., KARAKAŞ Z., et al.
55.th ASH Meeting, 7 - 10 December 2013, vol.122

Next Generation Sequencing Of The BCR ABL1 Kinase Domain May Be Beneficial In Decision Making Among Chronic Myeloid Leukemia Patients With Tyrosine Kinase Inhibitor Resistance

ERBİLGİN Y., Eşkazan E., HATIRNAZ NG Ö., Salihoğlu A., ELVERDİ T., Fırtına S., et al.
55.th ASH meeting, 7 - 10 December 2013, vol.122

ÇOCUKLUK ÇAĞI NÜKS AKUT LENFOBLASTİK LÖSEMİ HASTALARINDA TÜM GENOM SNP ARRAY ANALİZİ

ERBİLGİN Y., HATIRNAZ NG Ö., CELKAN T. T., FIRTINA S., CAN İ., ÜNÜVAR A., et al.
9. ULUSAL PEDİATRİK HEMATOLOJİ KONGRESİ, Turkey, 24 - 28 May 2013

Local RAS in Normal Hematopoietic and Multiple Myeloma related progenitor cells

UZ B., ÇATAL TATONYAN S., SAYİTOĞLU M., ERBİLGİN Y., HATIRNAZ NG Ö., AKSU S., et al.
4.th Internatiaonal Congress on Leukemia-Lymphoma-Myeloma, 22 - 25 May 2013

Expression Levels of Local RAS in Lymphoid and Myelid Malignancies

Çatal Tatonyn S., UZ B., SAYİTOĞLU M., ERBİLGİN Y., HATIRNAZ NG Ö., ÖZBEK U., et al.
ELN Frontiers Meeting, 09 November 2012

T HÜCRELİ AKUT LENFOBLASTİK LÖSEMİDE BİR TÜMÖR BASKILAYICI GEN OLARAK SNON SKIL

HATIRNAZ NG Ö., SAYİTOĞLU M., ERBİLGİN Y., ÖZTUNÇ C., AĞAOĞLU L., DEVECİOĞLU Ö., et al.
38. ULUSAL HEMATOLOJİ KONGRESİ, Turkey, 31 October - 03 November 2012

A Possible Tumor Suppressor role for SKIL Gene in T ALL

HATIRNAZ NG Ö.
7th Work Group Meeting COST Action BM0801, EuGESMA, 8 - 09 October 2012

REAL TIME PCR VE UYGULAMA ALANLARI

HATIRNAZ NG Ö.
UYGULAMALI MOLEKÜLER HEMATOLOJİ KURSU PROGRAMI, Turkey, 4 - 05 May 2012

KANTİTATİF PCR SONUÇLARININ DEĞERLENDİRİLMESİ

HATIRNAZ NG Ö.
UYGULAMALI MOLEKÜLER HEMATOLOJİ KURSU, Turkey, 23 - 24 December 2011

BCR ABL TRANSKRİPTİNİN TAYİNİNDE ULUSLARARASI SKALAYA GEÇİŞ

HATIRNAZ NG Ö., ERBİLGİN Y., TATONYAN S., ÖZTUNÇ C., UĞUREL E., KARABULUT A., et al.
37. ULUSAL HEMATOLOJİ KONGRESİ, Turkey, 19 - 22 November 2011

T HÜCRELİ AKUT LENFOBLASTİK LÖSEMİDE GENOM BOYU ANLATIM ANALİZLERİ

HATIRNAZ NG Ö., SAYİTOĞLU M., ERBİLGİN Y., ÖZTUNÇ C., STAAL F., VAN DONGEN J., et al.
3. DETAE GÜNLERİ, Turkey, 17 - 18 November 2011

A new noncoding risk factor for Acute Lymphoblastic Leukemia 8q24 region preliminary data

Can İ., HATIRNAZ NG Ö., ERBİLGİN Y., Öztunç C., SAYİTOĞLU M., ÖZBEK U.
The 3.rd EMBO meeting, 10 - 13 September 2011

Prognostic Implications of NOTCH1 and FBXW7 Mutations in Pediatric T Cell Acute Lymphoblastic Leukemia

ERBİLGİN Y., SAYİTOĞLU M., HATIRNAZ NG Ö., DOĞRU Ö., AKÇAY A., Tüysüz G., et al.
European School of Hematology, Scientific Workshop T-cell Acute Lymphoblastic Leukemia (T-ALL) Meets Normal T-cell Development, 7 - 09 May 2010

Mutations in Axin1 APC and Beta catenin Genes in T cell Acute Lymphoblastic Leukemia

SAYİTOĞLU M., ERBİLGİN Y., HATIRNAZ NG Ö., ÖZBEK U.
European School of Hematology, Scientific Workshop T-cell Acute Lymphoblastic Leukemia (T-ALL) Meets Normal T-cell Development, 7 - 09 May 2010

Dysregulated WNT Signaling in Childhood T cell Acute Lymphoblastic Leukemia

SAYİTOĞLU M., ERBİLGİN Y., HATIRNAZ Ö., Fırtına S., Tiemessen M., van Dongen J., et al.
European School of Hematology, Scientific Workshop T-cell Acute Lymphoblastic Leukemia (T-ALL) Meets Normal T-cell Development, 7 - 09 May 2010

LABORATUVAR UYGULAMALARININ TEORİĞİ

HATIRNAZ Ö.
KLINISYENLER İÇİN UGULAMALI MOLEKÜLER HEMATOLOJİ KURSU, Turkey, 19 - 20 February 2010

Expression Analysis of Some Candidate Genes Involved in Neurotransmission and Neurogenesis in Human Hippocampal Sclerosis

BEBEK N., SAYİTOĞLU M., özdemir ö., Baykan B., ÖZBEK U., Karasu A., et al.
American Academy of Neurology 63nd Annual Meeting, 4 - 08 December 2009

TÜM GENOM EKSPRESYON ANALİZLERİ

HATIRNAZ NG Ö.
2ndCOURSE IN INTEGRATION OF CYTOGENETICS MICROARRAYS AND MASSIVE SEQUENCING IN BIOMEDICAL AND CLINICAL RESEARCH HIBRID KURSU, Turkey, 18 - 22 November 2009

AKUT LÖSEMİLERDE ANORMAL WNT SİNYAL İLETİ YOLU AKTİVASYONU

SAYİTOĞLU M., HATIRNAZ NG Ö., ERBİLGİN Y., SİNEM Ö., AKTAŞ ÇETİN E., MAVİ N., et al.
1. DETAE GÜNLERİ, Turkey, 15 - 16 November 2009

MİKRO DİZİLİM TEKNOLOJİSİNİN T HÜCRELİ AKUT LENFOBLASTİK LÖSEMİ HASTALARININ GELİŞİM EVRELERİNE GÖRE SINIFLANDIRILMASI VE GEN ANLATIMI PROFİLLERİNİN SAPTANMASINDA KULLANIMI

HATIRNAZ Ö., SAYİTOĞLU M., ERBİLGİN Y., İNCİ Y., İNCİ Y., CELKAN T. T., et al.
1. DETAE GÜNLERİ, Turkey, 15 - 16 November 2009

B HÜCRELİ AKUT LENFOBLASTİK LÖSEMİ HASTALARINDA PAX5 GENİ MOLEKÜLER ANALİZLERİ

ÖZDEMİRLİ S., SAYİTOĞLU M., HATIRNAZ NG Ö., ERBİLGİN Y., MAVİ N., TİMUR Ç., et al.
35.ULUSAL HEMATOLOJİ KONGRESİ, Turkey, 7 - 10 November 2009

Mutation Analysis of c ABL Gene in Imatinib Resistant Chronic Myeloid Leukemia Patients

ERBİLGİN Y., Çatal S., HATIRNAZ NG Ö., SAYİTOĞLU M., SOYSAL T., ÖZBEK U.
MediMedGen Meeting, 28 June - 01 July 2009

Mutations in Axin 1 APC and B catenin Genes in Acute Lymphoblastic Leukemia

SAYİTOĞLU M., ERBİLGİN Y., HATIRNAZ NG Ö., Rourke E., ÖZBEK U.
MediMedGen Meeting, 28 June - 01 July 2009

Pax5 Expression Levels are increased in B Cell acute lymphoblastic leukemia patients

Fırtına S., SAYİTOĞLU M., ERBİLGİN Y., Mavi N., HATIRNAZ NG Ö., ÖZBEK U.
MediMedGen Meeting, 28 June - 01 July 2009

Beta catenin mediated deregulation of WNT signalling in T ALL

HATIRNAZ NG Ö.
20th Annual Meeting of the International BFM Study Group, 8 - 10 May 2009

T ALL HASTALARINDA NOTCH1 MUTASYONUNUN ARAŞTIRILMASI

ERBİLGİN Y., SAYİTOĞLU M., HATIRNAZ Ö., YÜKSEL L., İNCİ Y., AĞAOĞLU L., et al.
34. ULUSAL HEMATOLOJİ KONGRESİ, Turkey, 8 - 11 November 2008

EPIGENETIC INACTIVATION OF WNT5A BY PROMOTER METHYLATION IN ACUTE LEUKEMIA PATIENTS

ERBİLGİN Y., SAYİTOĞLU M., HATIRNAZ Ö., ÖZBEK U.
EMBO WORKSHOP ON GENOMIC IMPRINTING, 21 - 24 September 2008

T HÜCRELİ AKUT LENFOBLASTİK LÖSEMİ GELİŞİMİNDE ROL OYNAYAN ONKOGENİK YAZILIM FAKTÖRLERİNİN EKSPRESYONLARININ ARAŞTIRILMASI

SAYİTOĞLU M., ERBİLGİN Y., HATIRNAZ Ö., ÖZBEK U.
8. ULUSAL TIBBİ GENETİK KONGRESİ, Turkey, 6 - 09 May 2008

AKUT LÖSEMİ HASTALARINDA WNT SİNYAL İLETİ YOLU GENLERİNİN HİPERMETİLASYON ANALİZLERİ

HATIRNAZ Ö., SAYİTOĞLU M., ÖZBEK U.
33. ULUSAL HEMATOLOJİ KONGRESİ, Turkey, 16 - 19 November 2007

Detection of SOCS 1 suppressor of cytokine signaling 1 methylation in CML chronic myeloid leukemia patients

HATIRNAZ Ö., Ekmekçi C., AR M. C., ÜRE Ü. B., SOYSAL T., FERHANOĞLU A. B., et al.
31st FEBS Congress, 24 - 29 June 2006, vol.273

KRONİK MYELOİD LÖSEMİ GELİİMİNDE SOCS1 GEN METİLLENMESİN

HATIRNAZ Ö., EKMEKÇİ C. G., ÜRE Ü. B., FERHANOĞLU A. B., SOYSAL T., ÖZÇELİK H. T., et al.
7. ULUSAL PRENATAL TANI VE TIBBİ GENETİK KONGRESİ, Turkey, 17 - 20 May 2006

DETOKSİFİKASYON ENZİM GEN POLİMORFİZİMLERİNİN AKUT LÖSEMİ ETİYOLOJİSİNDEKİ ROLLERİ

SAYİTOĞLU M., HATIRNAZ Ö., ÖZBEK U.
30. ULUSAL HEMATOLOJİ KONGRESİ, Turkey, 10 - 14 November 2003

ALLELOTYPEFREQUENCIES OF TPMT CYP3A4 AND CYP23A5 GENES IN TURKISH POPULATION

ÖZBEK U., SAYİTOĞLU M., HATIRNAZ Ö.
5th INTERNATIONAL SYMPOSIUM ON LEUKEMIA AND LYMPHOMA, 12 May - 15 March 2003

Glutathione S Transferase T1 and M1 polymorphisms Susceptibility to childhood acute lymphoblastic leukemia ALL

SAYİTOĞLU M., HATIRNAZ NG Ö., SIRMA EKMEKCİ S., ANAK S. S., İnci Y., Ağaoğlu L., et al.
An İnternational Symposium Cancer 2002, 14 - 16 October 2002

Metabolising enzyme polymorphisms GSTM1 GSTT1 CYP1A1 CYP2D6 and their association as a potential susceptibility to pediatric ALL

ÖZBEK U., SAYİTOĞLU M., HATIRNAZ NG Ö., Ağaoğlu L., SIRMA EKMEKCİ S., Yüksel L., et al.
43rd American Society of Hematology Meeting, 7 - 11 December 2001

Gluthatione S Transferase T1 and M1 Polymoprhisms Susceptibilty to Childhood Acute Lymphoblastic Leukemia

SAYİTOĞLU M., HATIRNAZ Ö., SIRMA EKMEKCİ S., ANAK S. S., İNCİ Y., AŞICIOĞLU L., et al.
The Second European-American Intensive Course in Clinical and Forensic Genetics, 3 - 14 September 2001

Books & Book Chapters

CANCER EVOLUTION: FROM MULTISTEP CARCINOGENESIS TO CHROMOTHRIPSIS

Hatırnaz Ng Ö.
in: Cancer: From Genomics to Pharmaceutics, Zeynep Karakaş,Müge Sayitoğlu,Meryem Sedef, Editor, Istanbul Univ Press, Istanbul Univ Rectorate, İstanbul, pp.13-18, 2024

Hematolojik Malnitelerde Minimal Kalıntı Hastalığın Belirlenmesi

Hatırnaz Ng Ö.
in: HematoLog Genetik, Müge Sayitoğlu, Editor, Galenos, Ankara, pp.137-152, 2019

Nükleik asit yapısı ve işlevi

Hatırnaz Ng Ö., Arda E. Ş. N.
in: Tıbbi Genetiğin Esasları, uğur özbek, Editor, istanbul medikal sağlık ve yayıncılık, İstanbul, pp.13-21, 2014

DNA Analizi

Hatırnaz Ng Ö., Arda E. Ş. N.
in: tıbbi genetiğin esasları, uğur özbek, Editor, İstanbul medikal sağlık yayınevi, İstanbul, pp.41-54, 2014